News Release

View printer-friendly version
<< Back

DURECT Corporation Presenting at the Adams Harkness & Hill's 24th Summer Seminar

CUPERTINO, Calif., Aug 2, 2004 /PRNewswire-FirstCall via COMTEX/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it will present at the Adams, Harkness & Hill - 24th Annual Summer Seminar. The conference is being held at the Boston Marriott Long Wharf Hotel. Thomas A. Schreck, Chief Financial Officer, will be presenting at the conference on Thursday, August 5, 2004 at 8:00 a.m. EDT.

A live audio webcast of Mr. Schreck's presentation will be available by accessing DURECT's homepage at and clicking "Investor Relations."

DURECT Corporation ( is pioneering the development and commercialization of pharmaceutical systems for the treatment of chronic debilitating diseases and enabling biotechnology-based pharmaceutical products. DURECT's goal is to deliver the right drug to the right site in the right amount at the right time.


Schond L. Greenway, Executive Director, Investor Relations and
Strategic Planning of DURECT Corporation, +1-408-777-1417